Table of Contents
Introduction
-
- Definition
- Abbreviations
Executive Summary
-
- The market
-
- Figure 1: Best- and worst-case forecast of UK sales of OTC analgesics, 2008-18
- Market factors
-
- Figure 2: Retail value sales of OTC analgesics, by manufacturer, year ending May 2013
- Companies, brands and innovation
-
- Figure 3: New product launches in the pain relief market, brands and own-label, 2011-13
- Figure 4: New product launches in the pain relief market, by format type, January-June 2013
- The consumer
-
- Figure 5: Most popular treatments of aches and pains, May 2013
- Figure 6: Attitudes towards pain, May 2013
- What we think
Issues in the market
-
- How are brands remaining competitive against own-label?
- What impact will population changes have on this market?
- What launches have characterised development in 2012 and 2013 so far?
- Where are people buying OTC analgesics?
Trend Application
-
- Trend: Cam Cam
- Trend: Totophobia
- Futures Trend: East meets West
Market Drivers
-
- Key points
- Cold and flu incidences boosting the category in 2013
-
- Figure 7: Treatments sought, January 2013
- Stress-related aches and pains
-
- Figure 8: How often people take time to relax and unwind, November 2012
- Youngest demographics predicted to rise
-
- Figure 9: Trends in the age structure of the UK population, 2008-18
Who’s Innovating?
-
- Key points
- Branded products show greater innovation in topical analgesics
-
- Figure 10: New product launches in the pain relief market, brands and own-label, 2011-13
- Figure 11: Morrisons junior paracetamol launched in 2012
- Focus on topical treatments in 2013
-
- Figure 12: New product launches in the pain relief market, by format, 2011-13
- Figure 13: Examples of own-label topical analgesics launched in 2011
- Figure 14: Examples of branded topical analgesics launched in 2013 (year to June)
- Reckitt Benckiser leads launches in 2013
-
- Figure 15: New product launches in the pain relief market, by company, 2011-13
- Figure 16: Launches by reckitt benckiser in 2013
- Fast-acting is top in claims
-
- Figure 17: New product launches in the pain relief market, by claim, 2011-13
-
- Figure 18: Products aimed at children launched in 2013
Market Size and Forecast
-
- Key points
- Market remains steady as oral analgesics struggle for growth
-
- Figure 19: Value sales for OTC pain remedies, 2008-18
- Slow and steady growth driven by topical and paediatric analgesics
-
- Figure 20: Best- and worst-case forecast of UK sales of OTC analgesics, 2008-18
- Forecast methodology
Segment Performance
-
- Key points
- Oral analgesics struggling to grow
-
- Figure 21: Consumer spending on pain remedies, by segment, year ending April 2013
- Rise in sales of topical analgesics
-
- Figure 22: Consumer spending on OTC analgesics, by segment, year ending April 2012-April 2013
Market Share
-
- Key points
- Own-label shows the fastest growth
-
- Figure 23: Retail value sales of total OTC analgesics, by manufacturer, year ending May 2012 and May 2013
- Figure 24: Top 3 brands in pain relief, by segment, year ending May 2013
Companies and Products
-
- Boots
- Background and structure
- Strategy and performance
-
- Figure 25: Key financial data for Boots, 2011-12
- Product range and innovation
-
- Figure 26: Products launched by Boots in the UK pain relief market, Jan 2012-May 2013
- Marketing and advertising
- Reckitt Benckiser
- Background and structure
- Strategy and performance
-
- Figure 27: Key financial data for RB, 2011-12
- Product range and innovation
-
- Figure 28: Products launched by RB in the UK pain relief market, Jan 2012-May 2013
- Marketing and advertising
- The Mentholatum Company Ltd
- Background and structure
- Strategy and performance
-
- Figure 29: Key financial data for The Mentholatum Company, 2011-12
- Product range and innovation
- Marketing and advertising
- GlaxoSmithKline
- Background and structure
- Strategy and performance
-
- Figure 30: Key financial data for GSK, 2011-12
- Product range and innovation
-
- Figure 31: Products launched by GSK in the UK pain relief market, Jan 2012-May 2013
- Marketing and advertising
- Pfizer
- Background and structure
- Strategy and performance
-
- Figure 32: Key financial data for Pfizer, 2011-12
- Product range and innovation
-
- Figure 33: Products launched by Pfizer in the UK pain relief market, Jan 2012-May 2013
- Marketing and advertising
Brand Communication and Promotion
-
- Key points
- Fall in advertising spend in 2012
-
- Figure 34: Main media advertising expenditure on OTC analgesics, 2008-April 2013
- Reckitt Benckiser invests heavily in advertising in 2012
-
- Figure 35: Main media advertising expenditure on OTC analgesics, % by company, 2012
- Focus on brands aimed at children
-
- Figure 36: Main media advertising expenditure on OTC analgesics, by advertiser and brand, 2012
- TV remains the most expensive and widely used medium
-
- Figure 37: Main media advertising expenditure on OTC analgesics, % by media type, 2012
- Internet sees continued investment
-
- Figure 38: Main media advertising expenditure on OTC analgesics, % by media, 2011-13
Channels to Market
-
- Key points
- Grocery channel remains strong
-
- Figure 39: Distribution of OTC analgesics, 2010-12
The Consumer – Pains and Treatment
-
- Key points
- Pain experienced
-
- Figure 40: Pain experienced in the last six months, may 2013
- Women in more pain
- Age differences
- Headaches and menstrual pain most likely to result in taking OTC pain remedies
-
- Figure 41: Most popular treatments of aches and pains, May 2013
- Do men feel like they have to ‘man up’?
- Middle-aged most likely to take OTC analgesics
The Consumer – Shopping for OTC pain remedies
-
- Key points
- Efficacy claims are most important
-
- Figure 42: Factors influencing purchase of OTC analgesics, May 2013
- Recommendations are not very important
- Women are more price conscious
-
- Figure 43: Factors influencing purchase of OTC analgesics, May 2013
- Men need more guidance
The Consumer – Attitudes Towards Pain
-
- Key points
- Attitudes towards pain
-
- Figure 44: Attitudes towards pain, May 2013
- Resistance to taking remedies
- Frustration driving usage of OTC analgesics
Consumer Typologies
-
- Key points
-
- Figure 45: Consumer typologies, May 2013
- Price Sensitive
- Who are they?
- Cautious & Careful
- Who are they?
- Frustration Driven
- Who are they?
- Social Butterflies
- Who are they?
Appendix – Market Size and Forecast
-
-
- Figure 46: Value sales for OTC oral analgesics, 2008-18
- Figure 47: Consumer spending on oral analgesics, 2008-13 (est) and forecast to 2018
- Figure 48: Value sales for OTC paediatric analgesics, 2008-18
- Figure 49: Consumer spending on paediatric analgesics, 2008-13 (est) and forecast to 2018
-
- Figure 50: Value sales for OTC topical analgesics, 2008-18
- Figure 51: Consumer spending on topical analgesics, 2008-13 (est) and forecast to 2018
-
Appendix – Segment Performance
-
-
- Figure 52: Volume sales of OTC analgesics, by segment, year ending April 2012-April 2013
-
Appendix – Market Share
-
-
- Figure 53: Retail value sales of OTC oral analgesics (including oral lesions and toothache), by manufacturer, year ending May 2012 and May 2013
- Figure 54: Retail value sales of OTC topical analgesics, by manufacturer, year ending May 2012 and May 2013
- Figure 55: Retail value sales of OTC paediatric analgesics, by manufacturer, year ending May 2012 and May 2013
-
Appendix – The Consumer – Pains and Treatment
-
-
- Figure 56: Types of pain experienced, May 2013
-
- Figure 57: Most popular types of pain experienced, by demographics, May 2013
-
- Figure 58: Next most popular types of pain experienced, by demographics, May 2013
-
- Figure 59: Other types of pain experienced, by demographics, May 2013
-
- Figure 60: Repertoire of pains experienced, by demographics, May 2013
-
- Figure 61: Actions taken to treat pain, May 2013
-
- Figure 62: Most popular actions taken to treat headaches/migraines, by demographics, May 2013
-
- Figure 63: Next most popular actions taken to treat headaches/migraines, by demographics, May 2013
-
- Figure 64: Other actions taken to treat headaches/migraines, by demographics, May 2013
-
- Figure 65: Least popular actions taken to treat headaches/migraines, by demographics, May 2013
-
- Figure 66: Most popular actions taken to treat back pain, by demographics, May 2013
-
- Figure 67: Next most popular actions taken to treat back pain, by demographics, May 2013
-
- Figure 68: Other actions taken to treat back pain, by demographics, May 2013
-
- Figure 69: Least popular actions taken to treat back pain, by demographics, May 2013
-
- Figure 70: Most popular actions taken to treat arthritis or joint related pain, by demographics, May 2013
-
- Figure 71: Next most popular actions taken to treat arthritis or joint related pain, by demographics, May 2013
-
- Figure 72: Other actions taken to treat arthritis or joint related pain, by demographics, May 2013
-
- Figure 73: Least popular actions taken to treat arthritis or joint related pain, by demographics, May 2013
-
- Figure 74: Most popular actions taken to treat pain from sore/injured muscle/pain from sports/exercise/injury/general aches and pains from everyday life, my demographics, May 2013
-
- Figure 75: Next most popular actions taken to treat pain from sore/injured muscle/pain from sports/exercise/injury/general aches and pains from everyday life, my demographics, May 2013
-
- Figure 76: Other actions taken to treat pain from sore/injured muscle/pain from sports/exercise/injury/general aches and pains from everyday life, my demographics, May 2013
-
- Figure 77: Least popular actions taken to treat pain from sore/injured muscle/pain from sports/exercise/injury/general aches and pains from everyday life, my demographics, May 2013
-
- Figure 78: Most popular actions taken to treat menstrual pain, by demographics, May 2013
-
- Figure 79: Next most popular actions taken to treat menstrual pain, by demographics, May 2013
-
- Figure 80: Other actions taken to treat menstrual pain, by demographics, May 2013
-
- Figure 81: Least popular actions taken to treat menstrual pain, by demographics, May 2013
-
- Figure 82: Most popular actions taken to treat knee pain, by demographics, May 2013
-
- Figure 83: Next most popular actions taken to treat knee pain, by demographics, May 2013
-
- Figure 84: Other actions taken to treat knee pain, by demographics, May 2013
-
- Figure 85: Least popular actions taken to treat knee pain, by demographics, May 2013
-
- Figure 86: Repertoire of actions taken to treat headaches or migraines, by demographics, May 2013
-
- Figure 87: Repertoire of actions taken to treat back pain, by demographics, May 2013
-
Appendix – The Consumer – Factors Influencing Purchase
-
-
- Figure 88: Most popular purchase influencers of OTC pain remedies, by demographics, May 2013
-
- Figure 89: Next most popular purchase influencers of OTC pain remedies, by demographics, May 2013
-
- Figure 90: Other purchase influencers of OTC pain remedies, by demographics, May 2013
-
- Figure 91: Least popular purchase influencers of OTC pain remedies, by demographics, May 2013
-
Appendix – The Consumer – Shopping for OTC Pain Remedies
-
-
- Figure 92: Purchase influencers of OTC pain remedies, May 2013
-
- Figure 93: Attitudes towards pain and pain treatment, by most popular types of pain experienced, May 2013
-
- Figure 94: Attitudes towards pain and pain treatment, by next most popular types of pain experienced, May 2013
-
Appendix – The Consumer – Attitudes towards Pain
-
-
- Figure 95: Attitudes towards pain and pain treatment, May 2013
-
- Figure 96: Agreement with the statement ‘I get frustrated when pain gets in the way of things I want to do’, by demographics, May 2013
-
- Figure 97: Agreement with the statement ‘It’s best to try and fight the pain for as long as I can before I take non-prescription pain remedies’, by demographics, May 2013
-
- Figure 98: Agreement with the statement ‘It is easy to become reliant on non-prescription painkillers’, by demographics, May 2013
-
- Figure 99: Agreement with the statement ‘Suffering from pain makes me feel old’, by demographics, May 2013
-
- Figure 100: Agreement with the statement ‘Suffering from pain affects my social life’, by demographics, May 2013
-
- Figure 101: Agreement with the statement ‘All painkillers are the same so I don’t care which brand I use’, by demographics, May 2013
-
- Figure 102: Agreement with the statement ‘It is better for the body to treat pain with natural remedies first’, by demographics, May 2013
-
- Figure 103: Agreement with the statement ‘I am concerned about the side effects of non-prescription pain remedies’, by demographics, May 2013
-
- Figure 104: Agreement with the statement ‘It is important to change the type of pain relief you use so they remain effective’, by demographics, May 2013
-
- Figure 105: Agreement with the statement ‘I don’t pay attention to product claims for pain remedies’, by demographics, May 2013
-
- Figure 106: Agreement with the statement ‘Topical treatments, such as rubs are better for you than tablets’, by demographics, May 2013
-
- Figure 107: Agreement with the statement ‘It is important to take non-prescription painkillers at the first sign of any pain’, by demographics, May 2013
-
- Figure 108: Types of pain experienced, by repertoire of types of pain experienced, May 2013
-
Appendix – Consumer Typologies
-
-
- Figure 109: Attitudes towards pain and pain treatment, by target group, May 2013
-
- Figure 110: Target groups, by demographics, May 2013
-
- Figure 111: Types of pain experienced, by target group, May 2013
-
- Figure 112: Purchase influencers of OTC pain remedies, by target group, May 2013
-
- Figure 113: Attitudes towards shopping for OTC pain remedies, by target group, May 2013
-
- Figure 114: Actions taken to treat pain, by target group, May 2013
-
- Figure 115: Actions taken to treat pain, by target group, May 2013
-
- Figure 116: Actions taken to treat pain, by target group, May 2013
-
- Figure 117: Actions taken to treat pain, by target group, May 2013
-
- Figure 118: Actions taken to treat pain, by target group, May 2013
-
- Figure 119: Actions taken to treat pain, by target group, May 2013
-
Back to top